tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
FOLD is currently covered by 2 analysts with an average price target of $14.06. This is a potential upside of $5.79 (70.01%) from yesterday's end of day stock price of $8.27.
Amicus Therapeutics's activity chart (see below) currently has 124 price targets and 86 ratings on display. The stock rating distribution of FOLD is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 52.92% with an average time for these price targets to be met of 356.33 days.
Highest price target for FOLD is $16, Lowest price target is $12, average price target is $14.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 18-Sep-2025. First documented stock forecast 19-Aug-2014.
Currently out of the existing stock ratings of FOLD, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$14
$5.76 (69.90%)
21 days ago
(18-Sep-2025)
0/1 (0%)
$5.52 (65.09%)
Buy
$16
$7.8 (95.12%)
$17
7 months 12 days ago
(27-Feb-2025)
6/15 (40%)
$6.51 (68.60%)
454
Buy
$12
$3.8 (46.34%)
$18
9 months 27 days ago
(12-Dec-2024)
0/3 (0%)
$2.64 (28.21%)
Buy
$19
$10.76 (130.58%)
$17
1 years 4 months 29 days ago
(10-May-2024)
0/2 (0%)
$9.77 (105.85%)
Hold
$14
$5.8 (70.73%)
$11
1 years 5 months ago
(09-May-2024)
4/5 (80%)
$4.77 (51.68%)
165
What is FOLD (Amicus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?
Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?
Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?
